On March 19, 2026, electroCore, Inc. (NASDAQ: ECOR) announced its financial results for the year ended December 31, 2025, reporting record net sales of $32.0 million, a 27% increase from $25.2 million in 2024. This growth was driven by a 25% increase in the U.S. prescription business and a remarkable 97% rise in general wellness sales. The company also provided guidance for 2026, projecting approximately 30% annual revenue growth. In a significant leadership change, CEO Dan Goldberger will retire effective April 1, 2026, with Joshua Lev stepping in as interim President and CFO. The company has also appointed Michael Fox as Chief Operating Officer, aiming to strengthen its sales management team. The announcement was made during a conference call held on the same day, where the management expressed optimism about the company's future prospects in the bioelectronic technology sector.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.